Evidence map›Paper›PMID 29693246›Full record

ArticleBritish journal of haematology2018

Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.

Mary L McMaster, Chongkui Sun, Maria T Landi, Sharon A Savage, Melissa Rotunno, Xiaohong R Yang, Kristine Jones, Aurélie Vogt, Amy Hutchinson, Bin Zhu and 11 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of haematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Guideline
  2. A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Pooled it
  3. How telomere attrition protects against cancer.Nature reviews. Genetics · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. NAR molecular medicine · 2025
    Article
  12. Article
  13. Review
  14. GermlineGenes · 2024
    Review
  15. HemaSphere · 2023
    Article
  16. Article
  17. A Large-Scale Exome-Wide Association Study Identifies Novel Germline Mutations in Lung Cancer.American journal of respiratory and critical care medicine · 2023
    Article
  18. Population-based analysis ofJournal of medical genetics · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 1 country.

Mary L McMasterClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Chongkui SunLaboratory of Molecular Gerontology, National Institute on Aging/National Institute of Health, Baltimore, MD, USA.
Maria T LandiIntegrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Sharon A SavageClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Melissa RotunnoEpidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD, USA.
Xiaohong R YangIntegrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Kristine JonesCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Aurélie VogtCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Amy HutchinsonCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Bin ZhuCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Mingyi WangCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Belynda HicksCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Anand ThirunavukarasonLaboratory of Molecular Gerontology, National Institute on Aging/National Institute of Health, Baltimore, MD, USA.
Douglas R StewartClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Stella KoutrosOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Alisa M GoldsteinClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Stephen J ChanockDivision of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Neil E CaporasoOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Margaret A TuckerHuman Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.
Lynn R GoldinIntegrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH, Bethesda, MD, USA.ORCID 0000-0001-7350-446X
Yie LiuLaboratory of Molecular Gerontology, National Institute on Aging/National Institute of Health, Baltimore, MD, USA.
National Institutes of Health · USNational Institute on Aging · USNational Cancer Institute · US

Funding

Family Studies ZIACP004410 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$56.1M
STUDIES OF PERSONS AT HIGH RISK OF CANCER--GENETIC EPIDEMIOLOGYZ01CP004410 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI TUCKER, MARGARET · 1985 to 2008
$15.0M
Structure nucleases in telomere secondary structure resolutionZIAAG000754 · NIA · NATIONAL INSTITUTE ON AGING · PI LIU, YIE · 2013 to 2024
$8.4M
Exploring therapeutic intervention of telomere biology diseasesZIAAG000698 · NIA · NATIONAL INSTITUTE ON AGING · PI LIU, YIE · 2019 to 2025
$6.9M
Exploring a reliable and sensitive method to detect telomere dysfunction in the aging population and premature-aging diseasesZIAAG000789 · NIA · NATIONAL INSTITUTE ON AGING · PI LIU, YIE · 2018 to 2022
$2.2M
The role of telomeric protein dysfunction in human malignancyZIAAG000786 · NIA · NATIONAL INSTITUTE ON AGING · PI LIU, YIE · 2017 to 2018
$468k
Intramural NIH HHS Z01 CP004410Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

In a previous whole exome sequencing of patients from 41 families with Hodgkin lymphoma, we identified two families with distinct heterozygous rare coding variants in POT1 (D224N and Y36H), both in a highly conserved region of the gene. POT1 D224N mutant did not bind to a single-stranded telomere oligonucleotide in vitro suggesting the mutation perturbs POT1's ability to bind to the telomeric G-rich overhang. Human HT1080 cells expressing POT1 D224N and lymphoblastoid cells carrying Y36H both showed increased telomere length and fragility in comparison to wild type cells. This strongly suggests that mutant POT1 causes chromosome instability and may play a role in lymphomagenesis in these families.

Indexed as

Chromosomal InstabilityFamilyGerm-Line MutationHodgkin DiseaseMutation, MissenseTelomere-Binding ProteinsAmino Acid SubstitutionCell Line, TumorFemaleHumansMaleShelterin ComplexTelomerePOT1 protein, humanShelterin ComplexTelomere-Binding Proteinsgenetic analysisgenomic instabilityHodgkin lymphomaPOT1telomere

Identifiers

PMID29693246
PMCPMC5921926
OpenAlexW2800274246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.